Cite

HARVARD Citation

    Behrens, G. et al. (2021). SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination. Lancet. 398 (10305), pp. 1041-1042. [Online]. 
  
Back to record